Search for: "Janssen v. Janssen" Results 101 - 120 of 385
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
17 Jun 2017, 1:16 pm by Alexandre L. Dias Pereira
A full summary of this case has been published on Kluwer IP Law More from our authors: Competing for the Internet: ICANN Gate – An Analysis and Plea for Judicial Review Through Arbitration by Flip Petillion & Jan Janssen€ 205 The post Portugal: Expiration term to bring arbitration in patents v generics, Supreme Court of Justice of Portugal, 554/15.7YRLSB.L1.S1, 07 December 2016 appeared first… [read post]
15 Jun 2017, 12:37 am by Cheryl Beise
A full summary of this case has been published on Kluwer IP Law   More from our authors: Competing for the Internet: ICANN Gate – An Analysis and Plea for Judicial Review Through Arbitration by Flip Petillion & Jan Janssen€ 205 The post USA: Credit Acceptance Corp. v. [read post]
6 Jun 2017, 1:00 am by Rik Lambers
The District Court first considered relevant decisions from the German courts (LG Hamburg 2 April 2015, Warner-Lambert v A Pharma; OLG Düsseldorf 1 December 2015, KKH v Pfizer), and UK court (England and Wales Court of Appeal 28 May 2015 and 13 October 2016, Warner-Lambert v Actavis). [read post]
30 May 2017, 5:17 am by Howard Knopf
Janssen-Ortho Inc., 2009 FCA 212 (CanLII), where the need for explicit “acknowledgment” of the adoption of a party’s written submissions was addressed. [read post]
30 May 2017, 5:17 am by Howard Knopf
Janssen-Ortho Inc., 2009 FCA 212 (CanLII), where the need for explicit “acknowledgment” of the adoption of a party’s written submissions was addressed. [read post]
23 May 2017, 3:23 am by Kluwer UPC News blogger
The practical effect of the Supreme Court’s decision in Heartland v Kraft Foods will be to restrict a patentee’s choice to bring cases in patentee-friendly jurisdictions where findings of infringement and damages awards are higher than in other venues, namely the Eastern District of Texas. [read post]
19 May 2017, 9:27 pm by John Collins
Recently, the Full Federal Court of Australia considered Apotex’s applications to list products on Australia’s Pharmaceutical Benefits Scheme (PBS) before the expiry of a patent in Warner-Lambert Company LLC v Apotex Pty Limited [2017] FCAFC 58. [read post]
18 May 2017, 1:08 am by Thomas Long
A full summary of this case has been published on Kluwer IP Law   More from our authors: Competing for the Internet: ICANN Gate – An Analysis and Plea for Judicial Review Through Arbitration by Flip Petillion & Jan Janssen€ 205 The post USA: Nestle USA, Inc. v. [read post]
9 May 2017, 4:42 am
Searle LLC (2) Janssen Sciences Ireland UC [2017] EWHC 987 (Pat). [read post]
4 May 2017, 11:12 pm by Kluwer Blogger
A recent example of the court’s flexibility can be seen in Arnold J’s recent judgment in FAPL v BT [2017] EWHC 480 Ch. [read post]
4 May 2017, 1:00 am by Jiao Yuxin
Relevant Judicial Practice Boehringer Ingelheim Pharma GmbH & Co KG v. [read post]
3 May 2017, 3:30 am by Mark Engstrom
A full summary of this case has been published on Kluwer IP Law More from our authors: Competing for the Internet: ICANN Gate – An Analysis and Plea for Judicial Review Through Arbitration by Flip Petillion & Jan Janssen€ 205 The post USA: Securus Technologies, Inc. v. [read post]
3 May 2017, 3:20 am by Lars de Haas
Furthermore, the essentiality test (cf. the Guidelines H V 3.1) could not replace the “gold standard” because it could lead to different results A full summary of this case has been published on Kluwer IP Law More from our authors: Competing for the Internet: ICANN Gate – An Analysis and Plea for Judicial Review Through Arbitration by Flip Petillion & Jan Janssen€ 205 The post EPO:… [read post]
21 Apr 2017, 6:59 am by Brian Cordery
Penny sketched out the facts of the FKB v AbbVie litigation in the UK and the finding of Henry Carr J that it was appropriate to grant declarations that a dosage regime for a biosimilar product would have been anticipated or obvious at the priority date of a granted patent in the circumstances. [read post]